Recurrent and/or Metastatic Head and Neck Squamous

A Phase 2, Open-Label, Multicenter Study of INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Schedule an Appointment

Select an appointment date and time from available spots listed below.